Cited by 24Mast cells and histamineFood Allergy and Anaphylaxis ResearchDrug-Induced Adverse Reactions

Alpha-tryptase as a risk-modifying factor for mast cell–mediated reactions

Open access
Shin, Hannah, Lyons, Jonathan J.·2024·Current Allergy and Asthma Reports

Abstract

Purpose of review To provide an overview on the current understanding of genetic variability in human tryptases and summarize the literature demonstrating the differential impact of mature tryptases on mast cell-mediated reactions and associated clinical phenotypes.Recent findings It is becoming increasingly recognized that tryptase gene composition, and in particular the common genetic trait hereditary alpha-tryptasemia (HαT), impacts clinical allergy. HαT has consistently been associated with clonal mast cell disorders (MCD) and has also been associated with more frequent anaphylaxis among these patients, and patients in whom no allergic trigger can be found, specifically idiopathic anaphylaxis. Additionally, more severe anaphylaxis among Hymenoptera venom allergy patients has been linked to HαT in both retrospective and prospective studies. An increased relative number of α-tryptase-encoding gene copies, even in the absence of HαT, has also been associated with systemic mastocytosis and has been shown to positively correlate with the severity of mast cell-mediated reactions to vibration and food. These findings may be due to increased generation of α/β-tryptase heterotetramers and differences in their enzymatic activity relative to β-tryptase homotetramers. HαT is a naturally occurring overexpression model of α-tryptase in humans. Increased relative α-tryptase expression modifies immediate hypersensitivity symptoms and is associated with more frequent and severe mast cell-mediated reactions, ostensibly due to increased α/β-tryptase heterotetramer production.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11882-024-01136-y

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In individuals with HαT, α/β-tryptase heterotetramers increase vascular permeability by cleaving and activating PAR2 on endothelial cells, resulting in increased vascular leakage.

    “Recent studies have shown that in individuals with HαT, these heterotetramers increase vascular permeability by cleaving and activating protease-activated receptor-2 (PAR2) on endothelial cells, resulting in increased vascular leakage (14, 15).”

    From Defining “Normal” basal serum tryptase levels: a context-dependent approach to improve diagnostics in systemic mastocytosis (2025) · cites this paper as [15]

    The “Unique Activity of α/β-Tryptase Heterotetramers” section reports PAR2-dependent acute leakage in human endothelial cells exposed to the heterotetramers, but specifies that this was an in vitro finding. It says in vivo studies are needed, so it does not establish increased vascular leakage through this mechanism in individuals with HαT. Page numbers were not provided in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [49]Greiner G, Sprinzl B, Gorska A, Ratzinger F, Gurbisz M, Witzeneder N, Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis. Blood. 2020. PMC7116780 32777817
  2. [65]Polivka L, Madrange M, Bulai-Livideanu C, Barete S, Ballul T, Neuraz A, Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes. J Aller Clin Immunol. 2023. 37633651

Cited by

Sorted by citations

Authors
Shin, H., & Lyons, J. J.
Affiliations
University of California San Diego (US)
Corresponding author
Lyons, Jonathan J.
Venue
Current Allergy and Asthma Reports
Published
2024-03-09
Volume
24
Issue
4
Pages
199-209
ISSN
  • 1529-7322 (ISSN-L)
  • 1534-6315
OpenAlex
W4392619563
Cited by
24
References
88
Citations by year
2026: 9 · 2025: 11 · 2024: 4
FWCI
1.06
Type
journal article
Language
en
Open access
Locations
  • Current Allergy and Asthma Reports (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Allergy and Infectious Diseases (SI2 AI138586, R00AI138586)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
  • Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
  • Health Sciences › Medicine › Pharmacology › Drug-Induced Adverse Reactions
Keywords
hereditary alpha-tryptasemia, idiopathic anaphylaxis, anaphylaxis, clonal mast cell disorders, systemic mastocytosis, hymenoptera venom allergy, genetic variation, immediate hypersensitivity, food-induced anaphylaxis
MeSH terms
Mast Cell Activation Syndrome, Anaphylaxis, Humans, Mast Cells, Mastocytosis, Prospective Studies, Retrospective Studies, Tryptases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review